[HTML][HTML] COVID-19 and telepsychiatry: development of evidence-based guidance for clinicians
Background: The coronavirus disease (COVID-19) presents unique challenges in health
care, including mental health care provision. Telepsychiatry can provide an alternative to …
care, including mental health care provision. Telepsychiatry can provide an alternative to …
[HTML][HTML] Impact of the COVID-19 pandemic on the global delivery of mental health services and telemental health: systematic review
Background: The COVID-19 pandemic required mental health services around the world to
adapt quickly to the new restrictions and regulations put in place to reduce the risk of …
adapt quickly to the new restrictions and regulations put in place to reduce the risk of …
[HTML][HTML] A phase 2a randomised, double-blind, placebo-controlled, parallel-group, add-on clinical trial of ebselen (SPI-1005) as a novel treatment for mania or …
AL Sharpley, C Williams, AA Holder, BR Godlewska… - …, 2020 - Springer
Rationale Lithium is an effective prophylactic and anti-manic treatment in bipolar disorder;
however, its use is declining through perceived poor tolerance and toxicity. Lithium inhibits …
however, its use is declining through perceived poor tolerance and toxicity. Lithium inhibits …
[HTML][HTML] COVID-19 and substance use disorders: a review of international guidelines for frontline healthcare workers of addiction services
Background People with substance use disorders may be at a greater risk of contracting
COVID-19 infection and developing medical complications. Several institutional and …
COVID-19 infection and developing medical complications. Several institutional and …
[HTML][HTML] Clinical and health inequality risk factors for non-COVID-related sepsis during the global COVID-19 pandemic: a national case-control and cohort study
Background Sepsis, characterised by significant morbidity and mortality, is intricately linked
to socioeconomic disparities and pre-admission clinical histories. This study aspires to …
to socioeconomic disparities and pre-admission clinical histories. This study aspires to …
[HTML][HTML] Trends, variation, and clinical characteristics of recipients of antiviral drugs and neutralising monoclonal antibodies for covid-19 in community settings …
ACA Green, HJ Curtis, R Higgins, L Nab… - BMJ …, 2023 - ncbi.nlm.nih.gov
Trends, variation, and clinical characteristics of recipients of antiviral drugs and neutralising
monoclonal antibodies for covid-19 in community settings: retrospective, descriptive cohort …
monoclonal antibodies for covid-19 in community settings: retrospective, descriptive cohort …
[HTML][HTML] OpenSAFELY NHS Service Restoration Observatory 2: changes in primary care clinical activity in England during the COVID-19 pandemic
Background The COVID-19 pandemic has disrupted healthcare activity across a broad
range of clinical services. The NHS stopped non-urgent work in March 2020, later …
range of clinical services. The NHS stopped non-urgent work in March 2020, later …
[HTML][HTML] Identifying Patterns of Clinical Interest in Clinicians' Treatment Preferences: Hypothesis-free Data Science Approach to Prioritizing Prescribing Outliers for …
B MacKenna, HJ Curtis, LEM Hopcroft… - JMIR medical …, 2022 - medinform.jmir.org
Background: Data analysis is used to identify signals suggestive of variation in treatment
choice or clinical outcome. Analyses to date have generally focused on a hypothesis-driven …
choice or clinical outcome. Analyses to date have generally focused on a hypothesis-driven …
Impact of the COVID-19 pandemic on antipsychotic prescribing in individuals with autism, dementia, learning disability, serious mental illness or living in a care home …
O Macdonald, A Green, A Walker, H Curtis… - BMJ Ment …, 2023 - mentalhealth.bmj.com
Background The COVID-19 pandemic affected how care was delivered to vulnerable
patients, such as those with dementia or learning disability. Objective To explore whether …
patients, such as those with dementia or learning disability. Objective To explore whether …
[HTML][HTML] Changes in medication safety indicators in England throughout the covid-19 pandemic using OpenSAFELY: population based, retrospective cohort study of …
L Fisher, LEM Hopcroft, S Rodgers, J Barrett… - BMJ …, 2023 - ncbi.nlm.nih.gov
Changes in medication safety indicators in England throughout the covid-19 pandemic using
OpenSAFELY: population based, retrospective cohort study of 57 million patients using …
OpenSAFELY: population based, retrospective cohort study of 57 million patients using …